United States · FDA National Drug Code directory
Gavreto
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71332-006_af2c2115-cb7d-4679-935a-c2200487b965
- Product NDC
- 71332-006
- Form
- CAPSULE
- Composition / generic term
- Pralsetinib
- Labeler
- Rigel Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240624
- Source listing expiry
- 20271231
Source-listed ingredients
- PRALSETINIB — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 CAPSULE in 1 BOTTLE (71332-006-12) · 71332-006-12
- 60 CAPSULE in 1 BOTTLE (71332-006-60) · 71332-006-60
- 90 CAPSULE in 1 BOTTLE (71332-006-90) · 71332-006-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →